Réaction #2286355

ord-5e96555ae5634a62aeee7f61e18fe0fb

Équation de réaction

CCN(CC)CC
triethylamine
CC(C)(C)OC(=O)N1CCC(c2nc(C(=O)O)cs2)CC1
2-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1,3-thiazole-4-carboxylic acid
C[NH2+]OC.[Cl-]
methoxy(methyl)ammonium chloride
CCN=C=NCCCN(C)C.Cl
1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide HCl salt
CON(C)C(=O)c1csc(C2CCN(C(=O)OC(C)(C)C)CC2)n1
tert-Butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    workup.STIRRINGThe mixture was stirred at room temperature overnight
  2. 2
    AutreThe aqueous phase was separated off
  3. 3
    Extractionextracted with ethyl acetate
  4. 4
    SéchageThe combined organic phases are dried over sodium sulphate
  5. 5
    Concentrationconcentrated under reduced pressure
  6. 6
    AutreThe residue was purified chromatographically

Mode opératoire

At room temperature, triethylamine (324 mg) was added to a suspension of 2-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1,3-thiazole-4-carboxylic acid (1.0 g) in dichloromethane (30 mL). After ten minutes of stirring, methoxy(methyl)ammonium chloride (312 mg), 4-dimethylaminopyridine (39 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide HCl salt (675 mg) were added. The mixture was stirred at room temperature overnight, and water was then added. The aqueous phase was separated off and extracted with ethyl acetate. The combined organic phases are dried over sodium sulphate and concentrated under reduced pressure. The residue was purified chromatographically. This gave tert-butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (1.0 g).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09357779B2uspto-grants-2016_06